Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
UDOC.CNthis companyUnidoc Health Corp.	CA$0.05	-2.87×	-8.89×	9.89×	-3.08×	605.0%	7.0%	-331.9%	-344.7%	310.1%	373.7%	-25.9%	-0.03×	0.08×	-500.19×	0.33×	0.0%	2	-24.34	2	B-
AIML.CNAI/ML Innovations Inc.	CA$0.04	-1.5×	-12.15×	114.91×	-1.6×	-114.1%	-3310.4%	-7811.3%	-7652.0%	809.4%	-4637.1%	-56.7%	-1.23×	-0.11×	-138.1×	0.73×	0.0%	1	-42.17	2	C
DMED.CNDiagnamed Holdings Corp.	CA$0.03	-7×	-21.78×	0×	-6.86×	-115.6%	0.0%	0.0%	0.0%	311.7%	331.0%	-3.4%	0×	0.13×	0×	0.32×	0.0%	1	-46.73	2	C
HEM.VHemostemix Inc.	CA$0.05	-3.13×	-2.96×	0×	-4.14×	-154.2%	0.0%	0.0%	0.0%	94.8%	637.9%	-30.8%	-0.72×	-0.69×	-10.05×	0.49×	0.0%	1	-454.38	2	C
MDMA.CNPharmala Biotech Holdings Inc.	CA$0.17	-6.19×	5.47×	22.2×	-6.47×	-266.4%	-139.6%	-355.6%	-359.2%	-88.5%	-87.6%	-7.8%	0×	0.02×	0×	1.71×	0.0%	2	5.56	1	D+
NARA.CNPangenomic Health Inc.	CA$0.30	-2.42×	-3.87×	0×	-2.53×	-135.1%	0.0%	0.0%	0.0%	156.8%	173.2%	-22.2%	-0.1×	-0.05×	-835.72×	0.07×	0.0%	2	-346.8	—	—
Peer median	—	-3.13×	-3.87×	0×	-4.14×	-135.1%	0.0%	0.0%	0.0%	156.8%	173.2%	-22.2%	-0.1×	-0.05×	-10.05×	0.49×	0.0%	1	-46.73	2	—